Fintpla (fenfluramine) oral solution has been approved by the Japanese Ministry of Health, Labour, and Welfare (MHLW) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) as an add-on therapy to other anti-epileptic medicines for patients two years of age and older
Aclaris Therapeutics, Inc. announced positive results from its Phase III clinical trial, THWART-2 (WART-302), of A-101 45% Topical Solution (A-101...
Prismasol 4 mmol/l Potassium is used in the treatment of renal failure, as substitution solution in haemofiltration and haemodiafiltration and as dialysis solution in continuous haemodialysis or continuous haemodiafiltration. Prismasol 4 mmol/l Potassium solution may also be used in case of drug poisoning with dialysable or filterable substances. Prismasol 4 mmol/l Potassium solution is indicated in patients who are normokalaemic.